RAC Devices Exam Practice Questions & Study Guide: Elevate Your Preparation

Last updated: September 27, 2026

Preparing for the Regulatory Affairs Certification (RAC) Devices exam is one of the most important steps in advancing a career in medical device regulatory affairs. The RAC Devices credential, administered by the Regulatory Affairs Professionals Society (RAPS), validates your expertise in FDA device regulations, EU MDR/IVDR requirements, quality systems, and the full product lifecycle — from premarket submissions to post-market surveillance.

This guide gives you a free sample of RAC Devices practice questions and answers, each with a detailed explanation, so you can simulate the real exam environment and identify where to focus your study time. Below the sample questions, you'll also find guidance on exam structure, high-yield topics, and how our full RAC Devices Question Bank can help you prepare more efficiently.

Why RAC Devices Certification Matters

A RAC Devices certification signals to employers — from MedTech startups to global manufacturers — that you understand the regulatory frameworks governing medical devices in the U.S. and internationally. Regulatory affairs professionals who hold this credential are often better positioned for roles involving:

• FDA 510(k), De Novo, and Premarket Approval (PMA) submissions

• EU MDR/IVDR technical documentation and conformity assessment

• Quality management systems under ISO 13485 and FDA QSR (21 CFR 820)

• Risk management per ISO 14971

• Post-market surveillance, vigilance, and Medical Device Reporting (MDR)

• Combination product regulatory strategy

Because the exam draws from such a wide regulatory scope, structured practice with explanation-backed questions — not just answer keys — is one of the most effective ways to prepare.

What the RAC Devices Exam Covers

Candidates are typically tested across several domains, including:

1. Device classification and premarket pathways (510(k), PMA, De Novo, Special/Abbreviated 510(k))

2. Quality systems and design controls (ISO 13485, 21 CFR 820, Design History Files)

3. Risk management (ISO 14971)

4. Labeling and advertising requirements

5. Post-market obligations (MDR reporting, recalls, post-market surveillance)

6. International and combination product regulations

Understanding why an answer is correct — not just memorizing it — is what separates candidates who pass comfortably from those who struggle with the exam's scenario-based questions. That's the approach we've taken with every question below.

Sample RAC Devices Practice Questions with Detailed Explanations

Core Question Set

1. What is the primary purpose of a 510(k) submission? A. To provide proof of clinical efficacy for a device B. To demonstrate substantial equivalence to a legally marketed device C. To obtain approval for a new class of devices D. To ensure compliance with Good Manufacturing Practices (GMP)

Correct Answer: B A 510(k) submission exists to demonstrate that a new medical device is substantially equivalent to a legally marketed predicate device — meaning it has the same intended use and similar technological characteristics, or different characteristics that don't raise new questions of safety or effectiveness. Unlike a PMA, a 510(k) generally does not require independent proof of clinical efficacy; it relies on comparison to an already-cleared device.

2. Which of the following is the primary difference between a Class I and Class II medical device? A. Class II devices require clinical trials, while Class I devices do not B. Class I devices are subject to more stringent regulatory controls than Class II C. Class II devices typically require premarket notification (510(k)) D. Class I devices are exempt from FDA regulations

Correct Answer: C Class II devices carry moderate risk and typically require a 510(k) premarket notification to demonstrate substantial equivalence, along with "special controls" such as performance standards or specific labeling requirements. Class I devices, by contrast, are low-risk and are largely subject only to "general controls," with most exempt from premarket notification altogether.

3. What is the FDA's role in the regulatory approval of medical devices? A. FDA approves all devices before they enter the market B. FDA ensures the safety and effectiveness of medical devices, but does not approve all of them C. FDA only approves drugs and not medical devices D. FDA has no regulatory oversight over medical devices

Correct Answer: B It's a common misconception that every device on the U.S. market has been "FDA approved." In reality, most devices reach the market through FDA clearance (510(k)) rather than approval (PMA), and some low-risk Class I devices are exempt from premarket review entirely. The FDA's overarching mandate is to ensure devices are safe and effective, using a risk-based framework rather than a single approval pathway.

4. Which of the following documents is required for a Premarket Approval (PMA) submission? A. 510(k) B. Design History File (DHF) C. Clinical Data Study Protocol D. Annual Report

Correct Answer: B The Design History File compiles the records generated during a device's design and development, showing that the design was developed in accordance with the approved design plan and applicable regulatory requirements. It's a required element supporting a PMA submission, alongside clinical data, manufacturing information, and labeling.

5. What does the term "substantial equivalence" refer to in the context of FDA 510(k) submissions? A. A new device that is identical to an existing device B. A new device that is similar in intended use and performance to a legally marketed device C. A device that meets all FDA safety requirements D. A device that is more effective than a legally marketed device

Correct Answer: B Substantial equivalence does not mean identical — it means the new device has the same intended use and either the same technological characteristics as the predicate, or different characteristics that do not raise new questions of safety and effectiveness and are supported by data showing the device is at least as safe and effective.

6. What class of medical devices are typically subject to the lowest level of regulatory control? A. Class I B. Class II C. Class III D. Investigational Devices

Correct Answer: A Class I devices present the lowest risk to patients and are generally subject only to general controls (registration, listing, labeling, and good manufacturing practices), with most exempt from premarket notification.

7. Under the FDA's QSR (Quality System Regulations), which of the following must be implemented for a medical device manufacturer? A. Clinical trials for all devices B. A validated system for design control C. An annual review by the FDA D. Pre-market clinical trials

Correct Answer: B 21 CFR 820 (the Quality System Regulation) requires manufacturers to establish and maintain procedures for design control, ensuring specified design requirements are met throughout development, verification, and validation.

8. Which of the following is true regarding device labeling requirements under the FDA? A. Device labels are required to provide detailed clinical trial results B. Device labels must include the manufacturer's registration number C. Device labels must include a clear indication of intended use D. Device labels must be written in English only

Correct Answer: C Labeling must clearly communicate the device's intended use, along with directions for use, warnings, and contraindications, so that users and clinicians can safely and appropriately use the device.

9. In which of the following scenarios would a Class III medical device be required? A. When the device poses a high risk to the patient and requires premarket approval (PMA) B. For devices that are substantially equivalent to a legally marketed device C. For devices that have a low to moderate risk to patients D. For devices with a new intended use but no additional risks

Correct Answer: A Class III is reserved for devices that support or sustain life, are of substantial importance in preventing impairment of health, or present a potential unreasonable risk of illness or injury — these typically require PMA, including clinical data demonstrating safety and effectiveness.

10. What is the FDA's Medical Device Reporting (MDR) regulation designed to do? A. Ensure timely approval of devices B. Collect information on device performance and adverse events C. Manage product recalls D. Monitor the device's market competition

Correct Answer: B The MDR regulation (21 CFR 803) requires manufacturers, importers, and device user facilities to report deaths, serious injuries, and certain malfunctions to the FDA, supporting the agency's post-market surveillance function.

11. What is the difference between a 510(k) and a Premarket Approval (PMA)? A. 510(k) is for high-risk devices, while PMA is for low-risk devices B. PMA is a more stringent regulatory pathway that requires clinical data, while 510(k) does not C. 510(k) requires clinical trials, while PMA does not D. 510(k) is for devices with no predicate device, while PMA applies to those with a predicate

Correct Answer: B PMA is the most stringent device review pathway, generally reserved for Class III devices, and requires robust clinical evidence of safety and effectiveness. A 510(k) instead relies on comparison to a predicate device and typically does not require new clinical trial data.

12. What must be included in the Risk Management File according to ISO 14971? A. A detailed report of post-market surveillance B. A record of the device's performance and any adverse events C. A list of potential hazards and risk control measures D. A description of the manufacturing process

Correct Answer: C ISO 14971 requires manufacturers to identify hazards, estimate and evaluate the associated risks, implement risk control measures, and evaluate the overall residual risk — all documented in the Risk Management File throughout the device lifecycle.

13. What is the FDA's stance on combination products (e.g., drug-device combos)? A. Combination products are subject to the same regulations as individual devices B. Combination products require an additional review process that combines the regulations for both drugs and devices C. The FDA does not regulate combination products D. Combination products only need to meet one set of regulations, either drug or device

Correct Answer: B Combination products are assigned to a lead center (CDER, CDRH, or CBER) based on their primary mode of action, but review often draws on requirements from more than one regulatory framework, reflecting the product's combined drug and device components.

14. What does a Clinical Evaluation Report (CER) typically include? A. Details of the manufacturing process and quality controls B. A review of clinical studies and evidence regarding the device's safety and efficacy C. An analysis of the device's market competition D. A financial forecast for the device's lifecycle

Correct Answer: B A CER — a core requirement under EU MDR — synthesizes clinical data, literature, and post-market clinical follow-up to demonstrate that a device performs as intended and is safe for its intended purpose throughout its lifecycle.

15. Which of the following is a key requirement for maintaining FDA device approval? A. Annual clinical trials B. Post-market surveillance to monitor safety and performance C. Regular updates to labeling D. A new 510(k) submission every year

Correct Answer: B Regulatory obligations don't end at clearance or approval. Manufacturers must continue monitoring device performance in the field, reporting adverse events, and taking corrective action when safety signals emerge.

16. What is the role of the ISO 13485 standard in the medical device industry? A. To define the clinical trial protocols for medical devices B. To establish requirements for quality management systems C. To provide guidelines for medical device marketing D. To monitor post-market performance of medical devices

Correct Answer: B ISO 13485 sets out requirements for a quality management system specific to medical device design, development, production, and servicing — and is widely referenced or required by regulators worldwide, including under EU MDR/IVDR.

17. What is required for the approval of a new diagnostic device in the U.S.? A. FDA approval is not necessary for diagnostic devices B. Only clinical data is required for approval C. FDA clearance through the 510(k) process or approval through PMA D. A premarket notification to a third-party organization

Correct Answer: C In vitro diagnostic (IVD) devices follow the same general risk-based classification framework as other medical devices, meaning most reach the market via 510(k) clearance, with higher-risk diagnostics requiring PMA.

18. Which of the following does not typically require regulatory approval before market introduction? A. Class I devices B. Class II devices C. Class III devices D. Investigational devices

Correct Answer: A Most Class I devices are exempt from premarket notification and can be marketed after establishment registration and device listing, without FDA clearance or approval.

19. What is the primary responsibility of a Regulatory Affairs professional in the device industry? A. To conduct clinical trials B. To ensure compliance with regulatory requirements C. To oversee the manufacturing process D. To develop new devices

Correct Answer: B Regulatory Affairs professionals act as the bridge between a company's product development teams and global health authorities, ensuring every stage of the product lifecycle — design, testing, labeling, marketing, and post-market monitoring — meets applicable regulatory requirements.

20. What is the role of a Design History File (DHF) in the device development process? A. To demonstrate the financial performance of the device B. To document the design and development stages of a medical device C. To store post-market surveillance data D. To manage device recalls

Correct Answer: B The DHF is the compiled record of a device's design inputs, outputs, verification, validation, and design changes — serving as objective evidence that the finished design matches the approved design plan and meets user needs.

Bonus Questions from Our Exclusive Question Bank

Question 1: Primary Jurisdiction Over Vascular Grafts Which division would have primary jurisdiction over a vascular graft with an antibiotic based on primary mode of action? A. CDER B. CBER C. CDRH D. OCP

Correct Answer: C. The primary mode of action is that of the vascular graft (device), with the antibiotic being supportive — placing jurisdiction with the Center for Devices and Radiological Health (CDRH) rather than the drug or biologics centers.

Question 2: Modifications to Legally Marketed Devices A company wants to modify its legally marketed device such that the modification does not affect the intended use or alter the fundamental scientific technology of the device. If the design outputs of the modified device meet the design input requirements, this change would be best filed as a(n): A. Special 510(k) B. Abbreviated 510(k) C. Traditional 510(k) D. De novo 510(k)

Correct Answer: A. A Special 510(k) is appropriate when a manufacturer can rely on its existing, compliant design control process to support the change, without altering the device's intended use or fundamental technology.

Question 3: Production Regulations for Deodorants A personal deodorant manufacturer is required to do all of the following EXCEPT: A. Comply with GMP B. State the place of business on the label C. List the quantity of contents on the label D. Comply with export regulations when exporting product

Correct Answer: A. Under Section 602(b) of the FD&C Act, GMP compliance is recommended for cosmetics but is not a mandatory legal requirement in the same way it is for drugs and devices.

Question 4: 510(k) Requirements and Violations Under the statutory violations, failure to meet 510(k) requirements for a device that is required to have a 510(k) and is in commercial distribution is considered to be: A. Adulteration B. Improper use C. Misbranded D. Fraudulent

Correct Answer: C. A device marketed without a required 510(k) clearance is deemed misbranded under Section 502(o) of the FD&C Act.

Question 5: Class II Sutures Marketing Timeline A company's competitor is marketing a Class II suture which dissolves during the third week of use. The company's current product has to be removed by a physician. A change in weaving configuration gives this product the same dissolving time as the competitor's. When can the company's new suture be marketed? A. This requires a new 510(k). B. After submission in a periodic report C. After reporting clinical studies in an annual report D. After submission of labeling change

Correct Answer: A. Changing the suture's absorption/dissolving behavior alters its performance characteristics and effectively creates a new intended use profile, which requires a new 510(k) clearance before marketing.

Question 6: Quality System Regulations Exemptions Which of the following is exempt from Quality System regulations? A. Remanufacturers B. Custom device manufacturers C. Repackagers D. Component manufacturers

Correct Answer: D. Component manufacturers are excluded from GMP/QSR requirements per 21 CFR 820.1(a)(1), since components are not themselves finished devices.

Question 7: Device Failure and User Investigation If a device failure is occurring with greater than expected frequency and investigation of the problem implicates improper use by the end user, which of the following typically occurs? A. The labeling is revised. B. The product is recalled. C. The product is redesigned. D. A "Dear Doctor" letter is issued.

Correct Answer: A. When root-cause investigation points to user error rather than a device defect, the appropriate corrective action is usually to improve labeling and instructions for use so that the device is used correctly.

Question 8: Reporting Serious Adverse Events A physician reports to a manufacturer that a patient was hospitalized with acute sepsis after treatment with an approved device. This side effect is not listed in the package insert. This event must be reported by the manufacturer to FDA no later than: A. 5 calendar days B. 15 calendar days C. 30 calendar days D. The next quarterly or annual report

Correct Answer: C. Under 21 CFR 803.50(a), manufacturers must report serious injuries within 30 calendar days of becoming aware of the event.

Frequently Asked Questions About the RAC Devices Exam

How many questions are on the RAC Devices exam? The RAC Devices exam covers a broad range of topics across the device regulatory lifecycle, including classification, premarket pathways, quality systems, labeling, and post-market obligations. Because the exam blueprint can be updated by RAPS, candidates should always confirm the current format directly with RAPS before scheduling their exam.

What topics should I prioritize when studying for RAC Devices? High-yield areas typically include 510(k) and PMA pathways, device classification rules, ISO 13485 and FDA QSR requirements, ISO 14971 risk management, labeling regulations, and post-market surveillance/MDR reporting — all of which are represented in the sample questions above.

Is practicing with sample questions enough to pass the RAC Devices exam? Practice questions are most effective when paired with explanations that build conceptual understanding, not just memorized answers. Combining a structured question bank with a study handbook and, where possible, a practice test that mirrors the real exam format gives you the most complete preparation.

Do I need U.S. or EU regulatory experience to take the RAC Devices exam? While hands-on experience helps, structured study materials covering both FDA and EU MDR/IVDR frameworks — like the ones covered in our Question Bank and Master Handbook — can help candidates from any regulatory background build the knowledge needed to sit for the exam.

Maximize Your Exam Preparation with Our RAC Devices Question Bank

Looking for a thorough study tool to enhance your RAC Devices exam preparation? Our RAC Devices Question Bank includes 1000+ questions designed to help you practice and reinforce key regulatory concepts. Each question is paired with a detailed explanation to ensure you not only know the correct answer but also understand why it's correct.

Note: These are login-based tests, where you can attempt the questions and see answers at the end with explanation

Features of Our RAC Devices Question Bank:

• 1000+ Questions & Answers – Covering every aspect of the RAC Devices exam, ensuring you are fully prepared.

• In-depth Explanations – Each answer comes with a detailed explanation to help deepen your understanding.

• Updated Regularly – Stay up-to-date with the latest regulations and guidance in the industry.

• Real Exam Format – Prepare for the actual exam with questions formatted just like those you will face.

Why Choose Our RAC Devices Question Bank?

• Comprehensive Coverage – Thoroughly covers the topics that matter most, from device classification to FDA submission requirements.

• Efficient Study Tool – Focus your time on the most relevant questions and gain a deep understanding of key topics.

• Optimized for Success – Tailored to help you pass your RAC Devices exam with confidence.

Prepare effectively and confidently with our RAC Devices Question Bank. Get access now and take your first step towards earning your RAC certification!

Buy Question Bank using below link (the question bank will be instantly available after payment):

Buy Now (US): USD 79

Buy Now (EU): Euros 70

Note: These practice tests can be attempted immediately after purchase on our website. Please use chrome browser for best experience.

____________________________________________________________________________________________

Get Exclusive Study Material for RAC Devices by AptSkill

We offer RAC (Devices) Master Handbook, which is prepared as per RAC (Devices) Study Checklist.
Access table of content and learn more about out Handbook.

We also offer RAC (Devices) Practice Tests, learn more about Practice Tests here

Contact us at +91 8262083746 for any questions/clarifications.

Bonus: The books authored by AptSkill available too! reach out now!